"Binding Intellectual insights for your Business"
Nasal sprays are used to deliver medicines in the nasal cavities. Nasal sprays are available either as prescriptions or over-the-counter. They come in two types of containers, mainly pressurized canisters and pump bottles. They are used locally for conditions such as allergic rhinitis and nasal congestion. The surging number of allergies among people is driving the growth of the nasal spray packaging market.
Nasal sprays target inflammation in the nasal passages, which decreases swelling and helps clear up stuffiness. Some nasal sprays (steroid and antihistamine) are specifically developed to treat allergy symptoms and can be used for the long term. Furthermore, nasal sprays provide fast-acting relief for various symptoms, including nasal congestion. They work directly in the nasal passage, providing almost instant relief. Nasal sprays are easy to use and can be carried anywhere, which makes them a convenient option for relieving symptoms. Such benefits are contributing to the growth of the nasal spray packaging market.
Using nasal sprays for an extended time can lead to bleeding from the nose and even headaches. Some may experience other side effects, such as addiction or even congestion. These sprays can damage the nasal tissue and lead to inflammation in the nose, reducing the use of nasal spray and thus impeding the growth of the nasal spray packaging market. Moreover, the government's stringent rules for the safe packaging of pharmaceutical products are restricting the growth of this market.
The COVID-19 pandemic did not affect the pharmaceutical and related markets. Some sectors saw positive and exponential growth during that phase. The nasal spray was used to treat the virus and allergies. This led to moderate positive growth in the nasal spray packaging market.
The report covers the following key insights:
By Container Type | By Drug Type | By Dosage Type | By Geography |
|
|
|
|
Based on container type, the market is segmented into pressurized canisters and pump bottles. Pressurized canister is the dominating segment of the nasal spray packaging market. Pressurized canisters are generally used for multi-dose liquids and can be used for longer periods. The ease of use and convenience offered by these canisters is driving the segment growth.
Based on drug type, the market is segmented into liquid and powder. The liquid segment holds the largest share of the nasal spray packaging market. Liquid nasal spray helps pump measured doses and can be applied to the concerned area easily, propelling the segment growth.
Based on dosage type, the market is segmented into uni-dose, bi-dose, and multi-dose. The multi-dose segment is the dominating segment of the nasal spray packaging market. Multi-dose nasal sprays are generally used for chronic diseases or diseases that take longer to cure. These nasal sprays have a high capacity for product storage and reduce packaging waste as they are used for longer periods, bolstering the segment growth.
By region, the nasal spray packaging market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is the dominant region in the nasal spray packaging market. The presence of key market players such as Aptar Group Renaissance Lakewood, LLC, along with the well-established healthcare and pharmaceutical industry, is boosting the growth of this region. Asia Pacific is the fastest-growing region of the nasal spray packaging market. The growing population in the region and the rising number of allergies are causing a higher demand for such products in the market.
Europe is experiencing significant growth due to the surging geriatric population and the rise in chronic diseases due to the changing lifestyle and eating habits of people. Latin America will witness moderate growth during the forecast period. The high prevalence of allergic rhinitis and respiratory diseases is driving the regional expansion. The Middle East & Africa market is anticipated to grow steadily due to the rising number of asthma and other chronic disease patients.
The report includes the profiles of key players such as AptarGroup, Inc., Gerresheimer AG, Berry Global, Amcor plc, Bormioli Pharma S.p.A, Coster Tecnologie Speciali S.p.A., SGD Pharma, Berlin Packaging UK, Adelphi Healthcare Packaging, RENAISSANCE LAKEWOOD, LLC, and Silgan Holdings.
US +1 833 909 2966 ( Toll Free )